7th International Conference on Malignancies in AIDS and Other Immmunodeficiencies: Basic,
Epidemiologic and Clinical Research
April 28-29, 2003
Main Auditorium, Natcher Conference Center
National Institutes of Health Campus
Bethesda, Maryland, USA
Contact: Jaime Quinn, email jquinn@mail.nih.gov, fax 301-496-0826
Web Site: http://www3.cancer.gov/dctd/aids/conference
Deadline for Abstracts: February 17, 2003
What is the Scope of this Conference?
This Conference is a forum for the presentation of basic, epidemiologic and clinical aspects of research on malignancies in HIV-infected and other immunosuppressed individuals. Our objective is to enable information exchange between laboratory and clinically-based investigators to decrease the interval between basic discovery and clinical application.
This Conference will focus on basic and clinical research on the viral oncology, immunology, genetics, epidemiology, pathogenesis, drug discovery, early diagnosis, and clinical investigation of malignant diseases in AIDS and other immunodeficiency states including organ transplantation. We'll emphasize research on Human Papillomavirus (HPV), Epstein-Barr virus (EBV), and Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8 (KSHV/HHV-8) and their related malignancies including lymphomas, ano-genital carcinomas, Kaposi's Sarcoma and Hodgkin's Disease. Translational objectives such as basic target identification and validation, and preventive or therapeutic interventions are of particular interest. Other topics include interactions between viruses, somatic cell genetic changes, inherited and environmental risk factors, molecular genetics and biomarkers of disease, experimental models, novel clinical and therapeutic observations, epidemiology of etiologic agents or disease, and clinical outcomes.
The format will include invited lectures as well as oral and poster presentations of submitted abstracts. All clinical and laboratory investigators, post-docs, students, physicians, health care workers and others involved, interested, or participating in malignancy research in AIDS and other immunodeficiencies and in tumor virology are encouraged to attend.
